Type II diabetic rats and the hypolipidemic effect of camel milk

Journal of Food, Agriculture and Environment

Volumn 8, Issue 2, 2010, Pages 77-81

  Al Numair, Khalid S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Camel milk; Glibenclamide; Insulin; Lipid profiles; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; CAMEL MILK; CHOLESTEROL; FATTY ACID; GLIBENCLAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERLIPIDEMIA; MALE; MILK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA; RATTUS;

EID: 77952812623     PISSN: 14590255     EISSN: 14590263     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. American Diabetes Association (ADA) 2008. Diagnosis and classification of diabetes mellitus. Diabetes Care 31:S55-S60.
2. Muoio, D.M. and Newgard, C.B. 2008. Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nature Reviews Molecular Cell Biology 9:193-205. (Pubitemid 351301824)
3. Lee, S.H., Chun, H.K. and Lee, Y.S. 2003. The effect of rice germ oil supplement on serum and hepatic lipid levels of streptozotocin-induced diabetic mice. Korean Journal of Nutrition 36:543-5488.
4. Fujita, H., Yamagami, T. and Ohshima, K. 2003. Long-term ingestion of Touchi extract, an α-glucosidase inhibitor, by borderline and mild type-2 diabetic subjects is safe and significantly reduces blood glucose levels. Nutrition Research 23:713-722. (Pubitemid 36714298)
5. Lee, S.H., Chun, H.K., Park, H.J., Chang, S.O. and Lee, Y.S. 2004. Effects of c-oryzanol on blood glucose in diabetic KK mice. Journal of the Korean Society of Food Science and Nutrition 33:827-831. (Pubitemid 39039462)
6. Préstamo, G., Pedrazuela, A., Penãs, E., Lasunción, M.A. and Arroyo, G. X. 2004. Role of buckwheat diet on rats as prebiotic and healthy food. Nutrition Research 23:803-814.
7. Lee, S.H., Park, H.J., Cho, S.Y., Han, G.J., Chun, H.K. and Hwang, H.G. 2004. Supplementary effect of the high dietary fiber rice on lipid metabolism in diabetic KK mice. Korean Journal of Nutrition 37:81-87.
8. Gon, I.I., Valdivieso, L. and Garcia-Alonso, A. 2000. Nori seaweed consumption modifies glycemic response in healthy volunteers. Nutrition Research 20:1367-1375.
9. World Health Organization. 1980. Expert Committee on Diabetes Mellitus: Second Report. Technical Report Series No. 646. World Health Organization, Geneva, 66 p.
10. Hu, X., Sato, J., Oshida, Y., Yu, M., Bajotto, G. and Sato, Y. 2003. Effect of goshajinki-gan (Chinese herbal medicine: niu-che-sen-qi-wan) on insulin resistance in streptozotocin induced diabetic rats. Diabetes Research and Clinical Practice 59:103-111.
11. Beg, O.U., Von Bahr., Lindrom, H., Zaidid, Z.H. Jornvall, H. 1986. Characteristic of camel milk protein rich in proline identifies a new beta casein fragment. Regulation Peptides 15:55-61.
12. Knoess, K.H. 1979. Milk production of the dromedary. In Camels. IFS Symposium, Sudan, pp. 201-214.
13. Agrawal, R.P., Kochar, D. K., Sahani, M.S., Tuteja, F.C. and Ghorui, S.K. 2004. Hypoglycemic activity of camel milk in streptozotocin induced diabetic rats. International Journal of Diabetes in Developing Countries 24:47-49.
14. Trinder, P. 1969. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Annals of Clinical Biochemistry 6:24.
15. Burgi, W., Briner, M., Franken, N. and Kessler, A.C.H. 1988. One step sandwich enzyme immunoassay for insulin using monoclonal antibodies. Clinical Biochemistry 21:311-314.
16. Allain, C.C., Poon, L.S., Chan, C.S.G. et al. 1974. Enzymatic determination of total serum cholesterol. Clinical Chemistry 20:470-475.
17. McGowan, M.W., Artiss, J.D. and Strandbergh, D.R. et al. 1983. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clinical Chemistry 29:538-542. (Pubitemid 13160770)
18. Falholt, K., Lund, B. and Falholt, W. 1973. An easy colorimetric method for routine determination of free fatty acids in the plasma. Clinica Chimica Acta 46:105-111.
19. Zilversmit, D.B. and Davis, A.K. 1950.Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. Journal of Laboratory and Clinical Medicine 35:155-160.
20. Izzo, C., Grillo, F. and Murador, E. 1981. Improved method for the determination of high density lipoprotein cholesterol. Clinical Chemistry 27:371-374.
21. Friedwald, W.T., Levy, R.J. and Fredricken, D.S. 1972. Estimation of VLDL-cholesterol in the plasma without the use of preparative ultracentrifuge. Clinical Chemistry 18:449.
22. Attele, A.S., Zhou, Y.P., Xie, J.T., Wu, J.A., Zhang, L., Dey, L. et al. 2002. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51:1851-1858. (Pubitemid 34564298)
23. Tas, S., Sarandol, E., Ziyanok, S., Aslan, K. and Dirican, M. 2005. Effects of green tea on serum paraoxonase/arylesterase activities in streptozotocin induced diabetic rats. Nutrition Research 25:1061-1074. (Pubitemid 41739816)
24. Coniff, R.F., Shapiro, J.A., Seaton, T.B. and Bray, G.A. 1995. Multic enter, placebo controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non - insulin-dependent diabetes mellitus. American Journal of Medicine 98:443-451.
25. Coniff, R.F., Shapiro, J.A., Seaton, T.B., Hoogwerf, B.J., Hunt, J.A. 1995. A doubleblind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes. Diabetes Care 18:928-932.
26. Carrascosa, M., Pascual, F. and Arest, S. 1997. Acarbose-induced acute severe hepatotoxicity. Lancet 349:698-699.
27. Charpentier, G., Riveline, J.P. and Varroud-Vial, M. 2000. Management of drugs affecting blood glucose in diabetic patients with renal failure. Diabetes Medicine 26:73-85. (Pubitemid 30618360)
28. Ribnicky, D.M., Poulev, A., Watford, M., Cefalu, W.T. and Raskin, I. 2006. Antihyperglycemic activity of Tarralink, an ethanolic extract of Artemisia dracunculus L. Phytomedicine 13:550-557. (Pubitemid 44224045)
29. Lee, S.H., Park, H.J., Chun, H.K. and Lee, Y.S. 2004. Supplementary effect of c-oryzanol on lipid metabolism in diabetic KK mice. Korean Journal of Nutrition 37:347-351.
30. Singh, R. 2001. Annual Report. NRCC, Bikaner, 50 p.
31. Mehaia, M. A., Hablas, M. A., Abdel-Rahman, K. M. and El-Mougy, S. A. 1995. Milk composition of Majaheim, Wadah and Hamra camels in Saudi Arabia. Food Chemistry 52:115-122.
32. Begin-Heick, N., Dalpe-Scott, M., Rowe, J. and Heick, H.M. 1985. Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob mouse. Diabetes 34:179-184. (Pubitemid 15155969)
33. Richards-Williams, C., Contreras, J.L., Berecek, K. H. and Schwiebert, E. M. 2008. Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion. Purinergic Signal 4: 393-405.
34. Chen, M.-D., Liou, S.-J., Lin, P.-Y., Yang, V. C., Alexander, P. S. and Lin, W.-H. 1998. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Biological Trace Element Research 61:303-311.
35. Beg, O.U., Von Bahr-Lind Strom, H., Zaidi, Z.H. and Jornvall, H. 1986. A camel milk protein rich in half cystine. Primary structure assessment of variations, internal repeat patterns and relationship with neurophysin and other active polypeptides. European Journal of Biochemistry 5:195-201. (Pubitemid 16049730)
36. Fontbonne, A., Eschwege, E., Cambien, F., Richard, J.L., Ducimetiere, P., Thibult, N., Warnet, J.M., Claude, J.R. and Rosselin, G.E. 1989. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 32:300-304.
37. Motta, M., Giugno, I., Bosco, S., Pistone, G., Ruello, P., Maugeri, D. and Malaguarnera, M. 2001. Serum lipoprotein (a) changes in acute myocardial infarction. Panminerva Medica 43:77-80. (Pubitemid 33636951)
38. Grudy, M.S., Benjamin, I.J., Burke, G.L., Chait, A., Eckel, R.H. and Howard, B.V. 1999. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 100:1134-1146.
39. Lusis, J.A. 2000. Atheroscelerosis. Nature 407:233-241.
40. Kudchodkar, B.J., Lee, M.J., Lee, S.M., DiMarco, N.M. and Lacko, A.G. 1988. Effect of dietary protein on cholesterol homeostasis in diabetic rats. Journal of Lipid Research 10:1272-1287.
41. Braun, J.E. and Severson, D.L. 1992. Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochemical Journal 287:337-347.
42. Lopez-Virella, M.F., Wholtmann, H.J., Mayfield, R.K., Loadholt, C.B. and Colwell, J.A. 1983. Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients: A longitudinal study. Diabetes 32:20-25.
43. Frayn, K.N. 1993. Insulin resistance and lipid metabolism. Current Opinion in Lipidology 4:197-204.
44. Woodside, W. F. and Heimbery, M. 1972. Hepatic metabolism of free fatty acids in experimental diabetes. Irish Journal of Medical Sciences 8:309-316.
45. Draznin, B. and Eckel, RH. 1993. Diabetes and atherosclerosis. Molecular Basis and Clinical Aspects of Peutz-Jeghers Syndrome 12: 203.
46. Marsc, D., Knowled, P.F. and Rattle, H.W.F. 1996. Magnetic Response of Biomolecules. John Wiley and Sons, New York, 237 p.